Tocilizumab ELISA (mAb-based)
Enzyme immunoassay for the specific and quantitative determination of free Tocilizumab (Actemra®) in serum and plasma.
The solid phase (MTP) is coated by a highly specific monoclonal antibody directed against Tocilizumab. Another POD-labelled specific monoclonal antibody is used as conjugate.
Therefore any cross reactivity to the other therapeutical monoclonal antibodies is excluded.
Assay Format: Double specific mAb-based
Legal Status: CE-Mark
Intended Use: This kit has been developed for the measurement of drug levels in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Quality Control Certificates
The Kit at a glance:
|Required Volume (µL)||10|
|Incubation Time (min)||130|
|Sample||Serum or Plasma|
|Standard Range (ng/mL, 10x)||0-2000|
|Detection Limit (ng/mL)||5|
|Spike Recovery (%)||>95|
|Shelf Life (years)||2|